Security key
17322U207
- Security type / class
- Equity / COM
- Total 13F shares
- 25,142,423
- Total 13F value
- $51,075,151
- Share change
- -41,332
- Put/Call ratio
- 26%
- SEC-reported price per share
- $2.03
- Number of holders
- 69
- Value change
- -$897,312
- Number of buys
- 38
- Number of sells
- 33
Open additional details 1 more signal available
Report period
Q3 2021
Institutions
69
Top holders
10
CTXR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Citius Pharmaceuticals, Inc. SEC filings
Citius Pharmaceuticals, Inc. company facts
Citius Pharmaceuticals, Inc. 13D/G history
Broader feeds
Reporting periods
Holder history for CUSIP 17322U207
Recent filing periods:
Ownership snapshot
Top reported holders of CTXR - CITIUS PHARMACEUTICALS INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
0/15
Latest evidence
30 Jun 2021
13F
Highest disclosed value: $28,272,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock Finance, Inc. has the largest disclosed position value at $28.27M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock Finance, Inc.'s linked filing trail.
Disclosed position value
Top 5
BlackRock Finance, Inc.
$28.27M
VANGUARD GROUP INC
$19.67M
STATE STREET CORP
$6.85M
GEODE CAPITAL MANAGEMENT, LLC
$6.63M
RENAISSANCE TECHNOLOGIES LLC
$6.61M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$28,272,000
8,124,526 shares
|
— | 30 Jun 2021 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$19,672,000
5,652,813 shares
|
— | 30 Jun 2021 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$6,852,000
1,968,922 shares
|
— | 30 Jun 2021 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$6,631,000
1,905,508 shares
|
— | 30 Jun 2021 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
—
denominator unverified
|
$6,606,000
1,898,351 shares
|
— | 30 Jun 2021 |
| NORTHERN TRUST CORP |
13F
Company
|
—
denominator unverified
|
$4,519,000
1,298,509 shares
|
— | 30 Jun 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
69
Shares
25,142,423
Rows available
69
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2021 vs Q3 2025 Across Filers
Q3 2025 holders
1
Q3 2021 holders
69
Holder diff
68
| Investor | Q3 2025 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q3 2025 value | Q3 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend